Summary
46 / 100 · Bulios Score
What speaks for it
- Revenue grew by 37% a year over the last 3 years.
- It earns 17 USD a year on every 100 USD of invested capital.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $1.11M in the last fiscal year, 3.1% of its market value.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- It missed profit estimates 7 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 42% a year over 5 years. Over the last 3 years it grew by 37% a year. For the next fiscal year analysts expect revenue to grow by 5.8%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $82.0M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 188.6 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 4
- Hold 3
- Sell 0
Today's price within the analysts' price targets
The average target of $4 is 257% above today's price. 57% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Deferred license revenue 100%
By region
- Domestic 100%
- International 0.4%
Deferred license revenue brings in 100% of revenue.
Segments in detail